279 related articles for article (PubMed ID: 11441303)
1. [Report on the NIH Consensus Development Conference on Adjuvant Therapy of Breast Carcinoma].
Kaufmann M; von Minckwitz G
Onkologie; 2001 Apr; 24(2):190-2. PubMed ID: 11441303
[No Abstract] [Full Text] [Related]
2. Breast cancer: metastatic.
Johnston S; Stebbing J
Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
[No Abstract] [Full Text] [Related]
3. Adjuvant systemic therapy for early breast cancer: progress and controversies.
Hortobagyi GN
Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
[No Abstract] [Full Text] [Related]
4. Breast cancer: metastatic.
Johnston S; Stebbing J
Clin Evid; 2002 Dec; (8):1785-810. PubMed ID: 12603970
[No Abstract] [Full Text] [Related]
5. Consensus panel endorses range of adjuvant therapies for breast cancer.
McNeil C
J Natl Cancer Inst; 2000 Dec; 92(23):1870. PubMed ID: 11106671
[No Abstract] [Full Text] [Related]
6. [Adjuvant therapy in breast cancer].
Semiglazov VF
Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
[No Abstract] [Full Text] [Related]
7. The 1998 St. Gallen's Consensus Conference: an assessment.
Zujewski J; Liu ET
J Natl Cancer Inst; 1998 Nov; 90(21):1587-9. PubMed ID: 9811303
[No Abstract] [Full Text] [Related]
8. Adjuvant treatment of breast cancer.
Akerley WL
R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
[No Abstract] [Full Text] [Related]
9. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
Görner M; Just M; Gerull S
Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
[TBL] [Abstract][Full Text] [Related]
10. [Recommendations for adjuvant chemo- and hormone therapy of breast carcinoma].
Ridwelski K; Fahlke J
Zentralbl Chir; 1998; 123 Suppl 5():142-6. PubMed ID: 10063600
[TBL] [Abstract][Full Text] [Related]
11. [Subclinical heart damage caused by adjuvant anthracycline chemotherapy].
Dunst J
Strahlenther Onkol; 2002 Feb; 178(2):110-1. PubMed ID: 11942035
[No Abstract] [Full Text] [Related]
12. [Adjuvant therapy of breast cancer].
Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
[No Abstract] [Full Text] [Related]
13. Adjuvant treatment of breast cancer with exemestane.
Kunkler IH
N Engl J Med; 2004 Jul; 351(1):100-2; author reply 100-2. PubMed ID: 15229316
[No Abstract] [Full Text] [Related]
14. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000.
Cancer Control; 2001; 8(1):55. PubMed ID: 11176036
[No Abstract] [Full Text] [Related]
15. [Perspectives in oncology].
Jänicke F
Onkologie; 2003 Dec; 26 Suppl 7():3. PubMed ID: 14716134
[No Abstract] [Full Text] [Related]
16. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Zammit C; Yelland A; Deutsch G
Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550708
[No Abstract] [Full Text] [Related]
17. Trial data lacking for elderly patients with breast cancer.
Nelson NJ
J Natl Cancer Inst; 2000 Dec; 92(24):1968-9. PubMed ID: 11121451
[No Abstract] [Full Text] [Related]
18. Primary chemotherapy in surgically resectable breast cancer: the experience of the Milan Cancer Institute.
Valagussa P; Bonadonna G
Zentralbl Gynakol; 1996; 118(10):571. PubMed ID: 8912477
[No Abstract] [Full Text] [Related]
19. Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.
Wolff AC; Davidson NE
J Clin Oncol; 2006 Nov; 24(31):4949-51. PubMed ID: 17075110
[No Abstract] [Full Text] [Related]
20. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
